^
BIOMARKER:

ALK mutation

i
Other names: NBLST3, CD246, Anaplastic Lymphoma Kinase, Anaplastic Lymphoma Kinase (Ki-1), CD246 Antigen, Mutant Anaplastic Lymphoma Kinase, ALK, ALK Receptor Tyrosine Kinase, Anaplastic Lymphoma Receptor Tyrosine Kinase, ALK Tyrosine Kinase Receptor




Show legend

Include preclinical:
Non Small Cell Lung Cancer
Lung Non-Squamous Non-Small Cell Cancer
Neuroblastoma
Melanoma
crizotinib
lorlatinib
anlotinib
pembrolizumab
nivolumab
ceritinib
nivolumab + ipilimumab
crizotinib + alectinib
TGRX-326
sintilimab
alectinib
lorlatinib + TNO155
EGFR inhibitor
ALK inhibitor
Tyrosine kinase inhibitor
entrectinib
crizotinib + TNO155
ceritinib + TNO155